Literature DB >> 30303068

Age-related macular degeneration: treatment at what cost?

.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30303068     DOI： 10.1016/S0140-6736(18)32291-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Recent Advances of Computerized Graphical Methods for the Detection and Progress Assessment of Visual Distortion Caused by Macular Disorders.

Authors:  Navid Mohaghegh; Ebrahim Ghafar-Zadeh; Sebastian Magierowski
Journal:  Vision (Basel)       Date:  2019-06-05

2.  Impact of Treating Age-Related Macular Degeneration before Visual Function Is Impaired.

Authors:  Risa Aichi; Norihiro Nagai; Kishiko Ohkoshi; Yoko Ozawa
Journal:  J Clin Med       Date:  2022-09-27       Impact factor: 4.964

3.  Comparative efficacy and safety of anti-vascular endothelial growth factor regimens for neovascular age-related macular degeneration: systematic review and Bayesian network meta-analysis.

Authors:  Lu Ye; Zhao Jiaqi; Wang Jianchao; Feng Zhaohui; Yao Liang; Zhang Xiaohui
Journal:  Ther Adv Chronic Dis       Date:  2020-09-04       Impact factor: 5.091

Review 4.  Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option.

Authors:  Shuqi Qin; Ning Dong; Ming Yang; Jialin Wang; Xue Feng; Yanling Wang
Journal:  J Immunol Res       Date:  2021-07-29       Impact factor: 4.818
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.